Metformin for cardiovascular disease: promise still unproven

Affiliations

¹ Department of Cardiology, Hanzeplein 1, 9700 RB, PO Box 30001, Groningen, Netherlands; Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
² Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: i.c.c.van.der.horst@umcg.nl.

Free article

Comment

Chris P H Lexis et al. Lancet Diabetes Endocrinol. 2014 Feb.

Free article

. 2014 Feb;2(2):94-5.

doi: 10.1016/S2213-8587(13)70171-2. Epub 2013 Nov 7.

¹ Department of Cardiology, Hanzeplein 1, 9700 RB, PO Box 30001, Groningen, Netherlands; Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
² Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: i.c.c.van.der.horst@umcg.nl.

No abstract available

Comment on

Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study.
Meaney E, Vela A, Samaniego V, Meaney A, Asbún J, Zempoalteca JC, Elisa ZN, Emma MN, Guzman M, Hicks J, Ceballos G. Meaney E, et al. Clin Exp Pharmacol Physiol. 2008 Aug;35(8):895-903. doi: 10.1111/j.1440-1681.2008.04920.x. Epub 2008 Mar 13. Clin Exp Pharmacol Physiol. 2008. PMID: 18346173 Clinical Trial.
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P, Fisher M, Packard CJ, Sattar N. Preiss D, et al. Lancet Diabetes Endocrinol. 2014 Feb;2(2):116-24. doi: 10.1016/S2213-8587(13)70152-9. Epub 2013 Nov 7. Lancet Diabetes Endocrinol. 2014. PMID: 24622715 Clinical Trial.